1) moxibustion
艾注灸
2) Kang-ai injection
康艾注射液
1.
Effect of Kang-ai injection in recovery of primary hepatic carcinoma patient after interventional therapy;
康艾注射液对原发性肝癌患者介入治疗后康复的影响
3) Kang ai injection
康艾注射液
1.
Short-term therapeutic effect of integrated Kang ai injection and chemotherapy on patients with non-small cell lung cancer;
康艾注射液联合化疗治疗晚期非小细胞肺癌近期疗效
2.
Clinical observation of Kang ai injection combined with NP regimen in the treatment of advanced non-small cell lung cancer;
康艾注射液配合NP方案化疗治疗晚期非小细胞肺癌的临床观察
3.
Objective:This controlled study was to compared the clinical efficacy,side efect, clinical symptom and quality of life of FOLFOX4 regimen plus Kang ai injection and FOLFOX4 regimen chemotherapy alone,to evaluate the clinical value of Kang ai injection combined with FOLFOX4 regimen for advanced colonrectal cancer patients.
目的:本研究通过对比FOLFOX4方案联合康艾注射液组与单纯FOLFOX4化疗组在近期疗效、毒性反应、临床症状、体重变化及生存质量评分值等方面的差异,探讨康艾注射液联合化疗治疗晚期大肠癌的临床疗效和可行性。
4) Kangai injection
康艾注射液
1.
Clinical efficacy of combined chemotherapy with Kangai injection plus NP regimen in treatment of advanced non-small cell lung cancer;
康艾注射液加NP方案治疗晚期非小细胞肺癌的临床研究
2.
Kangai injection mixed with chemotherapy in intermediate and advanced-stage non-small cell lung cancer;
康艾注射液联合化疗治疗中晚期非小细胞肺癌的临床研究
3.
Clinical Study on Kangai injection Combined with Vinorelbine and Oxaliplatin in the Treatment of Advanced NSCLC Cancer;
康艾注射液加NO方案治疗晚期非小细胞肺癌的临床研究
5) Kang ai-injection
康艾注射液
1.
Clinical observation of Kang ai-injection with TACE in 34 patients with hepatocellular carcinoma(HC);
康艾注射液联合肝动脉化疗栓塞术治疗肝癌34例临床观察
补充资料：注灸
1.谓艾炷。注，通"炷"。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。